Search

Your search keyword '"Walker, Seth"' showing total 131 results

Search Constraints

Start Over You searched for: Author "Walker, Seth" Remove constraint Author: "Walker, Seth"
131 results on '"Walker, Seth"'

Search Results

1. LogoMotion: Visually Grounded Code Generation for Content-Aware Animation

3. Optofluidic Particle Manipulation: Optical Trapping in a Thin-Membrane Microchannel.

4. Optofluidic Particle Manipulation Platform with Nanomembrane.

7. Rethinking the Adolescent Mind in U.S. Schools

9. Exploring factors that influence the efficacy of functional communication training.

10. Increasing Accuracy of Rock-Climbing Techniques in Novice Athletes Using Expert Modeling and Video Feedback

16. Ivacaftor treatment of cystic fibrosis in children aged 12 to

17. Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial

18. The Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC) trial: Rationale and design of a multi-center, double-blind, placebo-controlled trial of high dose bolus administration of vitamin D3 during acute pulmonary exacerbation of cystic fibrosis

20. Differential Reinforcement Without Extinction and Stimulus Fading to Teach Tolerance of a Sleep Study.

30. Teaching Appropriate Feedback Reception Skills Using Computer-Based Training

32. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

34. Vitamin D for the Immune System in Cystic Fibrosis (DISC): a double-blind, multicenter, randomized, placebo-controlled clinical trial

37. My[Sacred]Space: discovering sacred space in cyberspace

38. TENNESSEE DEPARTMENT OF LIBRARY, ARCHIVES AND HISTORY

40. Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

44. The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States

45. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508delmutation: a double-blind, randomised, phase 3 trial

48. "It's Not A Fucking Book, It's A Weapon!": Authority, Power, And Mediation In The Book Of Eli.

Catalog

Books, media, physical & digital resources